ABSCI CORP Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
ABSCI CORP (ABSI) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 6.62 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-11
- ABSCI CORP share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 868.70K shares, a 39.97% decline year-over-year.
- ABSCI CORP share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 5.75M shares, a 52.80% increase year-over-year.
- ABSCI CORP share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 465.23K shares, a 90.05% increase year-over-year.
- ABSCI CORP share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 1.30M shares, a 29.93% increase year-over-year.
- ABSCI CORP share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 6.98M shares, a 23.01% increase from fiscal 2024.
- ABSCI CORP share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 5.67M shares, a 48.25% decline from fiscal 2023.
- ABSCI CORP share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 10.96M shares, a 42.74% increase from fiscal 2022.
- ABSCI CORP share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 7.68M shares, a 3.96% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 868.70K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | 6.62M shares 10-Q · filed 2026-08-11 | 7.09M shares derived: sum of 3 quarters · filed 2026-08-11 | 8.39M shares derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 5.75M shares 10-Q · filed 2026-05-07 | 6.22M shares derived: sum of 2 quarters · filed 2026-05-07 | 7.52M shares derived: sum of 3 quarters · filed 2026-05-07 | 8.97M shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 465.23K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | 1.77M shares derived: sum of 2 quarters · filed 2026-03-24 | 3.21M shares derived: sum of 3 quarters · filed 2026-03-24 | 6.98M shares 10-K · filed 2026-03-24 |
| 2025-09-30 | 1.30M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 2.75M shares derived: sum of 2 quarters · filed 2025-11-12 | 6.51M shares 10-Q · filed 2025-11-12 | 6.76M shares derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | 1.45M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 5.21M shares 10-Q · filed 2025-08-12 | 5.46M shares derived: sum of 3 quarters · filed 2025-08-12 | 6.46M shares derived: sum of 4 quarters · filed 2025-08-12 |
| 2025-03-31 | 3.76M shares 10-Q · filed 2025-05-13 | 4.01M shares derived: sum of 2 quarters · filed 2025-05-13 | 5.01M shares derived: sum of 3 quarters · filed 2025-05-13 | 5.47M shares derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-12-31 | 244.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | 1.25M shares derived: sum of 2 quarters · filed 2025-03-18 | 1.70M shares derived: sum of 3 quarters · filed 2025-03-18 | 5.67M shares 10-K · filed 2025-03-18 |
| 2024-09-30 | 1.00M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 1.46M shares derived: sum of 2 quarters · filed 2024-11-12 | 5.43M shares 10-Q · filed 2024-11-12 | 5.82M shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | 455.85K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 4.43M shares 10-Q · filed 2024-08-14 | 4.82M shares derived: sum of 3 quarters · filed 2024-08-14 | 8.14M shares derived: sum of 4 quarters · filed 2024-08-14 |
| 2024-03-31 | 3.97M shares 10-Q · filed 2024-05-14 | 4.36M shares derived: sum of 2 quarters · filed 2024-05-14 | 7.69M shares derived: sum of 3 quarters · filed 2024-05-14 | 8.19M shares derived: sum of 4 quarters · filed 2024-05-14 |
| 2023-12-31 | 394.05K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | 3.72M shares derived: sum of 2 quarters · filed 2024-03-21 | 4.22M shares derived: sum of 3 quarters · filed 2024-03-21 | 10.96M shares 10-K · filed 2024-03-21 |
| 2023-09-30 | 3.32M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | 3.82M shares derived: sum of 2 quarters · filed 2023-11-14 | 10.57M shares 10-Q · filed 2023-11-14 | 12.92M shares derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | 499.82K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 7.24M shares 10-Q · filed 2023-08-14 | 9.60M shares derived: sum of 3 quarters · filed 2023-08-14 | 10.64M shares derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | 6.74M shares 10-Q · filed 2023-05-15 | 9.10M shares derived: sum of 2 quarters · filed 2023-05-15 | 10.14M shares derived: sum of 3 quarters · filed 2023-05-15 | 11.03M shares derived: sum of 4 quarters · filed 2023-05-15 |
| 2022-12-31 | 2.36M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 3.40M shares derived: sum of 2 quarters · filed 2023-03-30 | 4.28M shares derived: sum of 3 quarters · filed 2023-03-30 | 7.68M shares 10-K · filed 2023-03-30 |
| 2022-09-30 | 1.04M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 1.93M shares derived: sum of 2 quarters · filed 2022-11-09 | 5.32M shares 10-Q · filed 2022-11-09 | 5.58M shares derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | 885.74K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 4.28M shares 10-Q · filed 2022-08-11 | 4.55M shares derived: sum of 3 quarters · filed 2022-08-11 | 5.18M shares derived: sum of 4 quarters · filed 2022-08-11 |
| 2022-03-31 | 3.40M shares 10-Q · filed 2022-05-11 | 3.66M shares derived: sum of 2 quarters · filed 2022-05-11 | 4.29M shares derived: sum of 3 quarters · filed 2022-05-11 | |
| 2021-12-31 | 263.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | 895.88K shares derived: sum of 2 quarters · filed 2022-03-22 | 7.39M shares 10-K · filed 2022-03-22 | |
| 2021-09-30 | 632.47K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 7.12M shares 10-Q · filed 2021-11-09 | ||
| 2021-06-30 | 6.49M shares 10-Q · filed 2021-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |